Aspartoacylase inhibitors are a class of chemical compounds specifically designed to target and inhibit the enzyme aspartoacylase. Aspartoacylase is an essential enzyme in the body involved in the breakdown of a compound called N-acetyl-L-aspartate (NAA). NAA is primarily found in the brain and plays a role in various cellular processes, including the synthesis of myelin, a fatty substance that insulates nerve fibers. The inhibition of aspartoacylase by these compounds is typically studied in research settings to investigate its effects on NAA levels and to gain a deeper understanding of the biochemical pathways involved in brain metabolism.
These inhibitors are typically small molecules or chemical agents that interact with aspartoacylase, disrupting its enzymatic activity. By inhibiting aspartoacylase, these compounds can lead to alterations in NAA levels within the brain, potentially impacting processes related to myelin formation and other cellular functions. Researchers use aspartoacylase inhibitors as valuable tools for studying the roles of NAA and aspartoacylase in neurological processes, and they are particularly relevant in the context of neurobiology and neuroscience research. While aspartoacylase inhibitors may have broader implications, their primary purpose is to assist scientists in elucidating the biochemical pathways and functions associated with aspartoacylase and NAA in brain metabolism and neurological processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
A histone deacetylase inhibitor that could potentially alter gene expression patterns, including those of ASPA. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
By inhibiting histone deacetylase, this compound may cause changes in chromatin structure affecting ASPA gene transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a potent histone deacetylase inhibitor, it could indirectly downregulate ASPA expression through epigenetic modulation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This cytidine analog may disrupt DNA methylation, possibly affecting the epigenetic regulation of the ASPA gene. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A hypomethylating agent that could lead to changes in gene expression, potentially including the downregulation of ASPA. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
This ribonucleotide reductase inhibitor can affect DNA synthesis and possibly gene expression profiles, including ASPA. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
An endocrine disruptor that could potentially alter hormone-mediated gene expression, potentially affecting ASPA. | ||||||
Lead(II) Acetate | 301-04-2 | sc-507473 | 5 g | $85.00 | ||
This heavy metal can affect numerous biological processes including gene expression, possibly leading to reduced ASPA levels. | ||||||